# Celanese Corp: Form 10-Q for the period ended Mar 31, 2021

- Company: [Celanese Corp](/companies/ce.md) (CIK 1306830)
- Form: 10-Q
- Filed: 2021-04-23
- Accepted by EDGAR: Apr 23, 2021, 16:20 ET
- Period: 2021-03-31
- Accession: 0001306830-21-000098
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1306830/000130683021000098/ce-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1306830/000130683021000098/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $1.80bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $1.31bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2021-01-01 to 2021-03-31 | $485.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2021-01-01 to 2021-03-31 | $20.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $137.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $326.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $25.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $85.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $322.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $2.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $2.84 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 114,028,145 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $116.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $92.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2021-01-01 to 2021-03-31 | $78.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2021-01-01 to 2021-03-31 | $267.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2021-03-31 | $3.71bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $10.76bn | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $1.94bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2021-03-31 | $3.13bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-03-31 | $497.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2021-03-31 | $3.54bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 42,625 characters.

*In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese U.S." refers to the Company's subsidiary, Celanese U.S. Holdings LLC, a Delaware limited liability company, and not its subsidiaries.*

*The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2020 filed on February 11, 2021 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Reporting on Form 10-K ("2020 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").*

*Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our 2020 Form 10-K.*

### Forward-Looking Statements

Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.

### COVID-19 Update

The COVID-19 pandemic and the various responses thereto, including government-imposed quarantines, stay-at-home restrictions, travel restrictions and other public health and safety measures, continue to evolve. Our employees' health and well-being continue to be of vital importance and we continue to monitor the pandemic in the areas where we have employees and operations. We have implemented government recommended protocols and best practices related to social distancing and best hygiene practices, including the use of additional personal protective equipment and enhanced cleaning protocols, where appropriate. We continue to implement our careful return-to-office efforts in accordance with government regulations and recommended protocols.

We operate within a geographically-balanced global footprint and have the ability to utilize different production and distribution strategies depending on the business and product to satisfy customer demands. We continue to pursue our existing operational strategy. Where we temporarily reduced run rates in prior quarters, our plants are now operating at more normalized levels, and we have been able to maintain a largely consistent supply chain. During the second half of 2020 and into 2021, consumer demand for most applications has increased within many regions of the world, particularly in China and the U.S., which have rebounded to pre-COVID-19 levels. We currently anticipate that the extent to which COVID-19 impacts customer demand and our results of operations will continue to decrease during the remainder of 2021, assuming effective rollout of vaccines and absent resurgences of COVID-19.

The duration and scope of COVID-19 continues to be uncertain. The extent to which the COVID-19 pandemic may adversely impact our business, financial condition and results of operations will depend on numerous evolving factors, including the effectiveness of vaccine distribution around the world, the extent and locations of any resurgences of the virus, health and safety measures and the continuing impact of the pandemic on supply chains (including the availability and cost of transportation and materials). These factors are uncertain, rapidly changing and cannot be predicted. For further information regarding the impact COVID-19 could have on our business, financial condition and results of operations, see *Part I - Item 1A. Risk Factors* in our Annual Report on Form 10-K for the year ended December 31, 2020. For further discussion of our liquidity condition, see *Liquidity and Capital Resources* in this *Part I - Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.*

### Risk Factors

See *Part I - Item 1A. Risk Factors* of our 2020 Form 10-K for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements:

- the extent to which the COVID-19 pandemic continues to adversely impact the economic environment, market demand and our operations, as well as the pace of any economic recovery;
- changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;
- the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;
- changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;
- the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases;
- the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance;
- the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants;
- increased price competition and the introduction of competing products by other companies;
- the ability to identify desirable potential acquisition targets and to complete acquisition or investment transactions, including obtaining regulatory approvals, consistent with our strategy;
- market acceptance of our technology;
- compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather, natural disasters, or other crises;
- the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us;
- changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations that may impact recorded or future tax impacts associated with the Tax Cuts and Jobs Act ("TCJA") and other potential regulatory and legislative tax developments in the United States or other jurisdictions;
- changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;
- potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change;
- potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate;
- changes in currency exchange rates and interest rates; and
- various other factors, both referenced and not referenced in this Quarterly Report.

Many of these factors are macroeconomic in nature and are, therefore, beyond our control. COVID-19 and responses to the pandemic by governments and businesses, have significantly increased financial and economic volatility and uncertainty, exacerbating the risks and potential impact of these factors. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates.

### Overview

We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.

Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions.

### Results of Operations

#### Financial Highlights

*(unaudited)*

*(In $ millions, except percentages)*

| Statement of Operations Data | Three Months Ended March 31, 2021 | 2020 | Change |
| --- | ---: | ---: | ---: |
| Net sales | 1,798 | 1,460 | 338 |
| Gross profit | 485 | 348 | 137 |
| Selling, general and administrative ("SG&A") expenses | (137) | (125) | (12) |
| Other (charges) gains, net | 6 | (6) | 12 |
| Operating profit (loss) | 326 | 194 | 132 |
| Equity in net earnings (loss) of affiliates | 29 | 57 | (28) |
| Non-operating pension and other postretirement employee benefit (expense) income | 38 | 28 | 10 |
| Interest expense | (25) | (28) | 3 |
| Dividend income - equity investments | 42 | 37 | 5 |
| Earnings (loss) from continuing operations before tax | 409 | 292 | 117 |
| Earnings (loss) from continuing operations | 324 | 227 | 97 |
| Earnings (loss) from discontinued operations | (1) | (7) | 6 |
| Net earnings (loss) | 323 | 220 | 103 |
| Net earnings (loss) attributable to Celanese Corporation | 322 | 218 | 104 |
| **Other Data** |  |  |  |
| Depreciation and amortization | 90 | 85 | 5 |
| SG&A expenses as a percentage of Net sales | 7.6% | 8.6% |  |
| Operating margin(1) | 18.1% | 13.3% |  |
| Other (charges) gains, net |  |  |  |
| Restructuring | (2) | (6) | 4 |
| Asset impairments | (1) | (4) | 3 |
| Plant/office closures | 9 | (1) | 10 |
| Commercial disputes | — | 5 | (5) |
| Total Other (charges) gains, net | 6 | (6) | 12 |

(1) Defined as Operating profit (loss) divided by Net sales.

*(unaudited)*

| Balance Sheet Data | As of March 31, 2021 (In $ millions) | As of December 31, 2020 |
| --- | ---: | ---: |
| Cash and cash equivalents | 791 | 955 |
| Short-term borrowings and current installments of long-term debt - third party and affiliates | 497 | 496 |
| Long-term debt, net of unamortized deferred financing costs | 3,135 | 3,227 |
| Total debt | 3,632 | 3,723 |

30

### Factors Affecting Business Segment Net Sales

The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows:

#### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

*(unaudited)*

|  | Volume (In percentages) | Price | Currency | Other | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Engineered Materials | 7 | 2 | 6 | — | 15 |
| Acetate Tow | (8) | — | — | — | (8) |
| Acetyl Chain | 5 | 25 | 2 | — | 32 |
| Total Company | 5 | 14 | 4 | — | 23 |

### Consolidated Results

#### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

Net sales increased $338 million, or 23%, for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- higher pricing in most of our segments, primarily driven by our Acetyl Chain segment due to increased customer demand in Asia and Europe and supply constraints across all regions;
- a favorable currency impact resulting from a stronger Euro relative to the U.S. dollar; and
- higher volume in our Acetyl Chain and Engineered Materials segments, primarily due to (i) our acquisition of Nouryon's redispersible polymer powders business offered under the Elotex® brand ("Elotex") in April of 2020 and (ii) increased demand due to recovery from the COVID-19 pandemic.

Operating profit increased $132 million, or 68%, for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- higher Net sales in our Acetyl Chain and Engineered Materials segments;

partially offset by:

- higher raw material costs within our Acetyl Chain and Engineered Materials segments;
- higher energy costs across all of our segments related to Winter Storm Uri; and
- higher costs in our Acetyl Chain segment as a result of fixed overhead, freeze-related repairs and restart costs resulting from Winter Storm Uri, as well as costs associated with running the Elotex business we acquired in April 2020.

Equity in net earnings (loss) of affiliates decreased $28 million for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- a decrease in equity investment in earnings of $21 million and $12 million from our Ibn Sina and Polyplastics strategic affiliates, respectively, primarily as a result of depressed global economic conditions and the previously disclosed sale of our investment in Polyplastics completed in October 2020.

Our effective income tax rate for the three months ended March 31, 2021 was comparable to the same period in 2020. See Note 13 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

### Business Segments

### Engineered Materials

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2021 | 2020 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 645 | 563 | 82 | 14.6% |
| **Net Sales Variance** |  |  |  |  |
| Volume | 7% |  |  |  |
| Price | 2% |  |  |  |
| Currency | 6% |  |  |  |
| Other | —% |  |  |  |
| Other (charges) gains, net | 7 | — | 7 | 100.0% |
| Operating profit (loss) | 130 | 102 | 28 | 27.5% |
| Operating margin | 20.2% | 18.1% |  |  |
| Equity in net earnings (loss) of affiliates | 25 | 53 | (28) | (52.8)% |
| Depreciation and amortization | 35 | 34 | 1 | 2.9% |

Our Engineered Materials segment includes our engineered materials business, our food ingredients business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry. Our food ingredients business is a leading global supplier of acesulfame potassium for the food and beverage industry and is a leading producer of preservatives, such as potassium sorbate and sorbic acid.

The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials. Therefore, in general, margins may expand or contract in response to changes in raw material costs.

#### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

Net sales increased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- higher volume for most of our products driven by increased demand in Europe and Asia due to recovery from the COVID-19 pandemic;
- a favorable currency impact resulting from a stronger Euro relative to the U.S. dollar; and
- higher pricing for most of our products, primarily due to increased customer demand and product mix, as well as supply disruptions primarily caused by Winter Storm Uri.

Operating profit increased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- higher Net sales; and
- a favorable impact of $7 million to Other (charges) gains, net. During the three months ended March 31, 2021, we recorded a $9 million gain on the termination of our Ferrara Marconi, Italy office lease, partially offset by $2 million in employee termination benefits, primarily related to business optimization projects. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information;

partially offset by:

- higher energy costs of $8 million, primarily due to supply disruptions caused by Winter Storm Uri; and
- higher raw material costs, primarily for methanol and ethylene, as a result of supply disruptions caused by Winter Storm Uri.

Equity in net earnings (loss) of affiliates decreased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- a decrease in equity investment in earnings of $21 million and $12 million from our Ibn Sina and Polyplastics strategic affiliates, respectively, primarily as a result of depressed global economic conditions and the previously disclosed sale of our investment in Polyplastics completed in October 2020.

### Acetate Tow

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2021 | 2020 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 119 | 129 | (10) | (7.8)% |
| **Net Sales Variance** |  |  |  |  |
| Volume | (8)% |  |  |  |
| Price | —% |  |  |  |
| Currency | —% |  |  |  |
| Other | —% |  |  |  |
| Other (charges) gains, net | — | (1) | 1 | 100.0% |
| Operating profit (loss) | 16 | 27 | (11) | (40.7)% |
| Operating margin | 13.4% | 20.9% |  |  |
| Dividend income - equity investments | 41 | 37 | 4 | 10.8% |
| Depreciation and amortization | 10 | 8 | 2 | 25.0% |

Our Acetate Tow segment serves consumer-driven applications. We are a leading global producer and supplier of acetate tow and acetate flake, primarily used in filter products applications.

The pricing of products within the Acetate Tow segment is sensitive to demand and is primarily based on the value of the product we produce. Many sales in this business are conducted under contracts with pricing for one or more years. As a result, margins may expand or contract in response to changes in market conditions over these similar periods, and we may be unable to adjust pricing also due to other factors, such as the intense level of competition in the industry.

#### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

Net sales decreased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- lower acetate tow volume, due to supply constraints as a result of acetic acid shortages caused by Winter Storm Uri.

Operating profit decreased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- lower Net sales.

### Acetyl Chain

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2021 | 2020 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 1,056 | 799 | 257 | 32.2% |
| **Net Sales Variance** |  |  |  |  |
| Volume | 5% |  |  |  |
| Price | 25% |  |  |  |
| Currency | 2% |  |  |  |
| Other | —% |  |  |  |
| Operating profit (loss) | 251 | 135 | 116 | 85.9% |
| Operating margin | 23.8% | 16.9% |  |  |
| Depreciation and amortization | 41 | 39 | 2 | 5.1% |

Our Acetyl Chain segment includes the integrated chain of our intermediate chemistry, emulsion polymers, ethylene vinyl acetate ("EVA") polymers and redispersible powders ("RDP") businesses. Our intermediate chemistry business produces and supplies acetyl products, including acetic acid, vinyl acetate monomer ("VAM"), acetic anhydride and acetate esters. These products are generally used as starting materials for colorants, paints, adhesives, coatings and pharmaceuticals. It also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products. Our emulsion polymers business is a leading global producer of vinyl acetate-based emulsions and develops products and application technologies to improve performance, create value and drive innovation in applications such as paints and coatings, adhesives, construction, glass fiber, textiles and paper. Our EVA polymers business is a leading North American manufacturer of a full range of specialty EVA resins and compounds, as well as select grades of low-density polyethylene. Our EVA polymers products are used in many applications, including flexible packaging films, lamination film products, hot melt adhesives, automotive parts and carpeting. Our RDP business is a leading manufacturer of redispersible polymer powders, sold under the Elotex® brand. The business produces polymer emulsions which are converted into powdered thermoplastic resin materials. RDP products are used in a variety of applications in the mortar industry, including decorative mortar, exterior insulation and finish systems, gypsum-based materials, plaster and render, self-leveling floor systems, skim coat and tile adhesives.

The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw material costs over months or quarters.

#### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

Net sales increased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- higher pricing for all of our products, primarily due to increased customer demand in Asia and Europe and supply constraints across all regions;
- higher volume primarily from RDP due to our acquisition of Elotex; and
- a favorable currency impact resulting from a stronger Euro relative to the U.S. dollar;

partially offset by:

- lower volume for VAM, due to supply constraints as a result of shortages caused by Winter Storm Uri.

Operating profit increased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- higher Net sales; and
- lower plant turnaround costs of $13 million, primarily related to our joint venture, Fairway, and Clear Lake plants in 2020;

partially offset by:

- higher raw material costs, primarily for ethylene and carbon monoxide, due to stronger demand and tighter market conditions;
- higher costs of $29 million as a result of fixed overhead, freeze-related repairs and restart costs resulting from Winter Storm Uri, as well as costs associated with running the Elotex business we acquired in April 2020; and
- higher energy costs of $19 million, primarily due to supply disruptions caused by Winter Storm Uri.

### Other Activities

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2021 | 2020 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Other (charges) gains, net | (1) | (5) | 4 | 80.0% |
| Operating profit (loss) | (71) | (70) | (1) | (1.4)% |
| Equity in net earnings (loss) of affiliates | 2 | 3 | (1) | (33.3)% |
| Non-operating pension and other postretirement employee benefit (expense) income | 38 | 28 | 10 | 35.7% |
| Dividend income - equity investments | 1 | — | 1 | 100.0% |
| Depreciation and amortization | 4 | 4 | — | —% |

Other Activities primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments.

#### Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

Operating loss was flat for the three months ended March 31, 2021 compared to the same period in 2020.

Non-operating pension and other postretirement employee benefit income increased for the three months ended March 31, 2021 compared to the same period in 2020, primarily due to:

- lower interest cost.

### Liquidity and Capital Resources

Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior unsecured revolving credit facility. As of March 31, 2021, we have $1.25 billion available for borrowing under our senior unsecured revolving credit facility, if required, in meeting our working capital needs and other contractual obligations. In addition, we held cash and cash equivalents of $791 million as of March 31, 2021. We are actively managing our business to maintain cash flow, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future.

While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.

Total cash outflows for capital expenditures are expected to be in the range of $500 million to $550 million in 2021, primarily due to additional investments in growth opportunities and productivity improvements primarily in our Engineered Materials and Acetyl Chain segments.

On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese U.S., have no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese U.S. in order to meet their obligations, including their obligations under senior credit facilities and senior notes, and to pay dividends on our Common Stock.

We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, India and Indonesia. Capital controls impose limitations on our ability to exchange currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling. While it is possible that future tightening of these restrictions or application of new similar restrictions could impact us, these limitations do not currently restrict our operations.

We remain in compliance with the financial covenants under our senior unsecured revolving credit facility and expect to remain in compliance based on our current expectation of future results of operations. If our actual future results of operations differ materially from these expectations, or if we otherwise experience increased indebtedness or substantially lower EBITDA, we may be required to seek an amendment or waiver of such covenants which may increase our borrowing costs under those debt instruments.

### Cash Flows

Cash and cash equivalents decreased $164 million to $791 million as of March 31, 2021 compared to December 31, 2020. As of March 31, 2021, $564 million of the $791 million of cash and cash equivalents was held by our foreign subsidiaries. Under the TCJA, we have incurred a prior year charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash. These funds are largely accessible without additional material tax consequences, if needed in the U.S., to fund operations.

- ***Net Cash Provided by (Used in) Operating Activities***

Net cash provided by operating activities decreased $143 million to $116 million for the three months ended March 31, 2021 compared to $259 million for the same period in 2020. Net cash provided by operating activities for the three months ended March 31, 2021 decreased, primarily due to:

- a payment for the European Commission settlement of $100 million, see Note 16 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for further information;
- an increase in other receivables of approximately $81 million, primarily due to higher charges billed to site partners as a result of Winter Storm Uri; and
- unfavorable trade working capital of $69 million, primarily due to an increase in trade receivables and inventory, partially offset by an increase in trade payables. Trade receivables increased as a result of the increase in Net sales and inventory increased as a result of higher costs for raw materials during the three months ended March 31, 2021. Payables increased as a result of higher costs due to Winter Storm Uri and the timing of settlement of trade payables;

partially offset by:

- an increase in Net earnings.
- ***Net Cash Provided by (Used in) Investing Activities***

Net cash provided by investing activities increased $226 million to $98 million for the three months ended March 31, 2021 compared to net cash used in investing activities of $128 million for the same period in 2020, primarily due to:

- an increase in proceeds from the sale of marketable securities of $200 million; and
- a decrease of $27 million in capital expenditures during the three months ended March 31, 2021.
- ***Net Cash Provided by (Used in) Financing Activities***

Net cash used in financing activities increased $355 million to $371 million for the three months ended March 31, 2021 compared to $16 million for the same period in 2020, primarily due to:

- a decrease in net borrowings on short-term debt of $259 million, primarily due to higher borrowings during the three months ended March 31, 2020, related to entering into an aggregate of $300 million in short-term bilateral loans; and
- an increase in share repurchases of our Common Stock of $100 million during the three months ended March 31, 2021.

### Debt and Other Obligations

There have been no material changes to our debt or other obligations described in our 2020 Form 10-K other than those disclosed above and in Note 8 - Debt in the accompanying unaudited interim consolidated financial statements.

### Accounts Receivable Securitization Facility

In July 2020, we entered into an amended and restated receivables purchase agreement under our U.S. accounts receivable securitization facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). We de-recognized $268 million of accounts receivable under this agreement as of March 31, 2021. Unsold U.S. accounts receivable of $50 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2021.

### Factoring and Discounting Agreements

We have factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. We de-recognized $36 million and $233 million of accounts receivable under these factoring agreements as of March 31, 2021 and December 31, 2020, respectively.

In March 2021, we entered into an agreement in Singapore with a financial institution to discount, on a non-recourse basis, documentary credits or other documents recorded as accounts receivable. The Company de-recognized $20 million of accounts receivable under this agreement as of March 31, 2021.

### Guarantor Financial Information

The Senior Notes were issued by Celanese U.S. ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group"). See Note 8 - Debt in the accompanying unaudited interim consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Parent Guarantor and Subsidiary Guarantors represent substantially all of the Company's U.S. assets and business operations. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.

The Parent Guarantor and the Subsidiary Guarantors have guaranteed the Senior Notes on a full and unconditional, joint and several, senior unsecured basis. The guarantees are subject to certain customary release provisions, including that a Subsidiary Guarantor will be released from its respective guarantee in specified circumstances, including (i) the sale or transfer of all of its assets or capital stock; (ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction. Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it ceases to guarantee the Issuer's obligations under the Credit Agreement (subject to the satisfaction of customary document delivery requirements). The obligations of the Subsidiary Guarantors under their guarantees are limited as necessary to prevent such guarantees from constituting a fraudulent conveyance or fraudulent transfer under applicable law.

The Parent Guarantor and the Issuer are holding companies that conduct substantially all of their operations through their subsidiaries, which own substantially all of our consolidated assets. The Parent Guarantor has no material assets other than the stock of its immediate 100% owned subsidiary, the Issuer. The principal source of cash to pay the Parent Guarantor's and the Issuer's obligations, including obligations under the Senior Notes and the guarantee of the Issuer's obligations under the Credit Agreement, is the cash that our subsidiaries generate from their operations. Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor. While the Credit Agreement and the Indentures generally limit the ability of our subsidiaries to restrict payment of dividends or other distributions to us, these limitations are subject to certain qualifications and exceptions, which may have the effect of significantly limiting the applicability of those restrictions.

For cash management purposes, the Company transfers cash between the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. While the non-guarantor subsidiaries do not guarantee the Issuer's obligations under our outstanding debt, the transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Senior Notes, Credit Agreement, the Company's other outstanding debt, Common Stock dividends and Common Stock repurchases.

The summarized financial information of the Obligor Group is presented below on a combined basis after the elimination of: (i) intercompany transactions among such entities and (ii) equity in earnings from and investments in the non-guarantor subsidiaries. Transactions with, and amounts due to or from, non-guarantor subsidiaries and affiliates are separately disclosed.

*(unaudited)*

|  | Three Months Ended March 31, 2021 (In $ millions) |
| --- | ---: |
| Net sales to third parties | 344 |
| Net sales to non-guarantor subsidiaries | 186 |
| Total net sales | 530 |
| Gross profit | 29 |
| Earnings (loss) from continuing operations | (28) |
| Net earnings (loss) | (29) |
| Net earnings (loss) attributable to the Obligor Group | (29) |

38

*(unaudited)*

|  | As of March 31, 2021 (In $ millions) | As of December 31, 2020 |
| --- | ---: | ---: |
| Receivables from non-guarantor subsidiaries | 303 | 318 |
| Other current assets | 1,280 | 1,597 |
| Total current assets | 1,583 | 1,915 |
| Goodwill | 399 | 399 |
| Other noncurrent assets | 3,576 | 3,519 |
| Total noncurrent assets | 3,975 | 3,918 |
| Current liabilities due to non-guarantor subsidiaries | 1,265 | 1,206 |
| Current liabilities due to affiliates | 60 | 58 |
| Other current liabilities | 971 | 958 |
| Total current liabilities | 2,296 | 2,222 |
| Noncurrent liabilities due to non-guarantor subsidiaries | 1,591 | 1,593 |
| Other noncurrent liabilities | 3,562 | 3,648 |
| Total noncurrent liabilities | 5,153 | 5,241 |

### Share Capital

We declared a quarterly cash dividend of $0.68 per share on our Common Stock on April 14, 2021, amounting to $77 million.

There have been no material changes to our share capital described in our 2020 Form 10-K other than those disclosed above and in Note 11 - Stockholders' Equity in the accompanying unaudited interim consolidated financial statements.

### Contractual Obligations

Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2020 Form 10-K.

### Off-Balance Sheet Arrangements

We have not entered into any material off-balance sheet arrangements.

### Critical Accounting Policies and Estimates

Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.

We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our 2020 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2020 Form 10-K.

### Recent Accounting Pronouncements

See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements.

## Market risk

As filed, 482 characters.

Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2020 Form 10-K. See also Note 14 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations.

## Controls and procedures

As filed, 857 characters.

### Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of March 31, 2021, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.

### Changes in Internal Control Over Financial Reporting

During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Apr 23, 2021.
Source: SEC EDGAR, the filing index for accession 0001306830-21-000098. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
